<VariationArchive VariationID="427885" VariationName="11p15.1 deletion" VariationType="Deletion" Accession="VCV000427885" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2017-07-17" MostRecentSubmission="2017-07-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="418960" VariationID="427885">
      <GeneList>
        <Gene Symbol="HPS5" FullName="HPS5 biogenesis of lysosomal organelles complex 2 subunit 2" GeneID="11234" HGNC_ID="HGNC:17022" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>11p15.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="18278670" stop="18322174" display_start="18278670" display_stop="18322174" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_021160006.1" start="27496" stop="71101" display_start="27496" display_stop="71101" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="18300216" stop="18343720" display_start="18300216" display_stop="18343720" Strand="-" />
          </Location>
          <OMIM>607521</OMIM>
        </Gene>
      </GeneList>
      <Name>11p15.1 deletion</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.1</CytogeneticLocation>
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="11p15.1 deletion AND Hermansky-Pudlak syndrome 5" Accession="RCV000494784" Version="3">
        <ClassifiedConditionList TraitSetID="805">
          <ClassifiedCondition DB="MedGen" ID="C3888004">Hermansky-Pudlak syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-03-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-03-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-07-17" MostRecentSubmission="2017-07-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28640947</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="805" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9855" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 5</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome+5/8539" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013557" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS5</ElementValue>
                <XRef Type="MIM" ID="614074" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18334" />
                <XRef ID="18334" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <XRef ID="231512" DB="Orphanet" />
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C3888004" DB="MedGen" />
              <XRef ID="MONDO:0013557" DB="MONDO" />
              <XRef Type="MIM" ID="614074" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1129175" SubmissionDate="2017-05-02" DateLastUpdated="2017-07-17" DateCreated="2017-07-17">
        <ClinVarSubmissionID localKey="11p15.1 deletion|OMIM:614074" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000579445" DateUpdated="2017-07-17" DateCreated="2017-07-17" Type="SCV" Version="1" SubmitterName="Laboratoire de Génétique Moléculaire, CHU Bordeaux" OrgID="506172" OrganizationCategory="laboratory" OrgAbbreviation="GenMol" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">28640947</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS5" />
          </GeneList>
          <Name>11p15.1 deletion</Name>
          <VariantType>Deletion</VariantType>
          <Location>
            <CytogeneticLocation>11p15.1</CytogeneticLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614074" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28640947</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28640947</ID>
        </Citation>
        <Comment>(1,4kb from chr11:18327845 to chr11:18329253)</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB2621390</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1129175" TraitType="Disease" MappingType="XRef" MappingValue="614074" MappingRef="OMIM">
        <MedGen CUI="C3888004" Name="Hermansky-Pudlak syndrome 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

